At this time, posts about ABL Bio are rapidly increasing on portals and stock communities. Today, foreigners have tentatively purchased a net 46,000 shares of ABL Bio, while institutions have sold a net 8,000 shares. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

As of 11:30 AM on the 10th, ABL Bio's stock price is 27,200 KRW, up 21.7% from the previous day, with a trading volume of 19,383,563 shares, which is 699.31% of the 5-day average trading volume. On June 4th, ABL Bio was a market topic for its "upward trend following confirmation of Phase 1 clinical trial results for an anticancer drug."

In addition to ABL Bio, posts by investors are also rapidly increasing for Roborobo (215100), Shinshin Pharmaceutical (002800), and Hanwha 3WoB (00088K).

※Source: AI Investment Assistant AI Lassiro

※ This article was generated in real time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing